IMAGES

  1. Frontiers

    rheumatoid arthritis experimental study

  2. Advances in experimental models of rheumatoid arthritis

    rheumatoid arthritis experimental study

  3. IJMS

    rheumatoid arthritis experimental study

  4. Experimental Models for Rheumatoid Arthritis

    rheumatoid arthritis experimental study

  5. Frontiers

    rheumatoid arthritis experimental study

  6. Frontiers

    rheumatoid arthritis experimental study

VIDEO

  1. Experimental Arthritis Treatment energetically progammed audio Ver 2 0

  2. Rheumatoid Arthritis

  3. Hard Decisions

  4. Karen's Story

  5. NIH Science in Seconds

  6. Arthritis: Update

COMMENTS

  1. A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis

    Li Z, Hu J, Bao C, et al. Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study. Clin Exp Rheumatol 2020;38:732-741. PubMed

  2. Systematic review of robust experimental models of rheumatoid arthritis

    Systematic review of robust experimental models of rheumatoid arthritis for basic research. Author links open overlay panel Lin Ye 1, Hu Mingyue 1, Zhang Feng 1, Dai Zongshun 1, Xie Ying 2, Cai Xiong 1, Liu Liang 2. ... Arthritis Research & Therapy, 6 (6) (2004), pp. R544-550. View in Scopus Google Scholar

  3. Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis

    The abovementioned studies about the mechanism of miRNAs have shown promising results in experimental models of arthritis, and their efficacy needs more clinical trials to prove. Consisting of more than 200 nucleotides in length, lncRNAs are identified as long non-coding RNAs and are widely expressed in various tissues of the human body.

  4. Recent progress in treatments of rheumatoid arthritis: an overview of

    Genovese MC, Weinblatt ME, Aelion JA. et al. ABT-122, a bispecific dual variable domain immunoglobulin targeting tumor necrosis factor and interleukin-17a, in patients with rheumatoid arthritis with an inadequate response to methotrexate: a randomized, double-blind study. Arthritis Rheumatol 2018; 70:1710-20.

  5. Deconstruction of rheumatoid arthritis synovium defines ...

    Cell states associated with rheumatoid arthritis versus osteoarthritis in a previous study of more than 5,000 synovial cells were also associated with rheumatoid arthritis in this dataset ...

  6. Immunotherapy for rheumatoid arthritis

    Rheumatoid arthritis (RA) is an autoimmune, inflammatory condition that causes progressive destruction of joints. Most patients have only transient responses to current therapies, and very few ...

  7. Efficacy outcomes in phase 2 and phase 3 randomized controlled ...

    Forest plots visualizing ORs ± 95% CI for achieving ACR 20/50/70 responses in rheumatoid arthritis phase 2 studies compared to phase 3 studies. Each row represents data for the three main ...

  8. Upadacitinib monotherapy versus methotrexate monotherapy in patients

    Rheumatoid arthritis (RA) is a systemic inflammatory disease that can cause impaired functional ability, chronic pain, and increased mortality rates if not properly treated [].Methotrexate (MTX) is the most commonly used first-line therapeutic choice for RA due to its well-known safety profile and demonstrated effectiveness in reducing disease activity and preventing joint damage [2,3,4].

  9. An overview of multi-omics technologies in rheumatoid arthritis

    Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease with a complex pathological mechanism involving autoimmune response, local inflammation and bone destruction. Metabolic pathways play an important role in immune-related diseases and their immune responses. The pathogenesis of ...

  10. Emerging therapies in rheumatoid arthritis: focus on monoclonal

    The efficacy and safety of subcutaneous clazakizumab in patients with moderate-to-severe rheumatoid arthritis and an inadequate response to methotrexate: results from a multinational, phase IIb, randomized, double-blind, placebo/active-controlled, dose-ranging study. Arthritis Rheumatol. 2015; 67 (10):2591-600.

  11. Advances in experimental models of rheumatoid arthritis

    Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by persistent articular inflammation and joint damage. RA was first described over 200 years ago; however, its etiology and pathophysiology remain insufficiently understood. The current treatment of RA is mainly empirical or based on the current understanding of ...

  12. A randomized, placebo-controlled experimental medicine study of RIPK1

    Receptor-interacting protein kinase 1 (RIPK1) is a key mediator of inflammation through cell death and proinflammatory cytokine production. This multicenter, randomized, double-blind (sponsor-unblinded), placebo-controlled, experimental medicine study evaluated the safety, pharmacokinetics (PK), and preliminary efficacy of GSK2982772, a RIPK1 inhibitor, in moderate to severe rheumatoid ...

  13. Modeling Rheumatoid Arthritis In Vitro: From Experimental Feasibility

    Rheumatoid arthritis (RA) is a chronic, inflammatory, and systemic autoimmune disease that affects the connective tissue and primarily the joints. If not treated, RA ultimately leads to progressive cartilage and bone degeneration. The etiology of the pathogenesis of RA is unknown, demonstrating heterogeneity in its clinical presentation, and is ...

  14. Considerations for Optimal Trial Design for Rheumatoid Arthritis

    Rheumatoid arthritis prevention studies provide an important experimental framework for generating deeper insights into risk stratification and for refining trial design in the future. To this end, a research agenda is suggested, together with some considerations for imaging and for biological sampling. This commentary concludes with some of ...

  15. Scientists target gut microbiome to treat rheumatoid arthritis in world

    Rheumatoid arthritis affects one in 50 people, with about 456,000 Australians living with the autoimmune disease A Queensland-based study is focusing on improving the gut microbiome by using 'live ...

  16. Animal models of rheumatoid pain: experimental systems and insights

    Severe chronic pain is one of the hallmarks and most debilitating manifestations of inflammatory arthritis. It represents a significant problem in the clinical management of patients with common chronic inflammatory joint conditions such as rheumatoid arthritis, psoriatic arthritis and spondyloarthropathies. The functional links between peripheral inflammatory signals and the establishment of ...

  17. Novel rheumatoid arthritis drug succeeds in clinical trial

    Rheumatoid arthritis patients getting little or no relief from conventional small-molecule drugs and injectable biologic drugs saw substantial improvement in their condition from daily use of an experimental compound in a large 24-week study led by a Stanford University School of Medicine investigator.. A paper describing the results of the double-blind, randomized phase-3 clinical trial was ...

  18. Rheumatoid Arthritis Clinical Trials

    The purpose of this study is to get synovial tissue from patients with rheumatoid arthritis by minimally invasive ultrasound guided biopsy, for the purpose of identifying the processes that are responsible for the cause of the disease. A Study to Evaluate Inflammation of the Heart Muscle Tissue in Patients with Rheumatoid Arthritis Rochester, MN.

  19. Switching on resolution to treat RA moves closer to reality

    Notably, resolvin D1 is detected in synovial fluid from patients with RA and can accelerate the resolution of experimental arthritis 8. Altogether, the results of the study by Alivernini et al. 1 ...

  20. Rheumatology

    Basic research in the division includes models of rheumatoid arthritis and systemic lupus erythematosus as well as investigations into how diseases develop. Scientists work with biospecimens from people with rheumatoid arthritis, systemic lupus erythematosus, inflammatory myositis, vasculitis and scleroderma.

  21. impact of exogenous hormone treatment on rheumatoid arthritis

    This Editorial refers to 'Effects of oral contraceptives and menopausal hormone therapy on the risk of rheumatoid arthritis: a prospective cohort study' by Hadizadeh et al. 2024;63:2101-8. The impact of sex hormones on rheumatic diseases such as rheumatoid arthritis (RA) is well-known.

  22. Rheumatoid arthritis patients harbour aberrant enteric bacteriophages

    Objectives Viruses have been considered as important participants in the development of rheumatoid arthritis (RA). However, the profile of enteric virome and its role in RA remains elusive. This study aimed to investigate the atlas and involvement of virome in RA pathogenesis. Methods Faecal samples from 30 pairs of RA and healthy siblings that minimise genetic interferences were collected for ...

  23. Etiology and Risk Factors for Rheumatoid Arthritis: A State-of-the-Art

    Introduction. Rheumatoid arthritis (RA) is a chronic immune-mediated multisystemic disease that mainly localizes to the joints. It is the most common systemic inflammatory rheumatic disease (1, 2) and it is associated with considerable morbidity and disability, as well as increased mortality ().In the last decades, the prognosis of RA patients has been dramatically improved by the expansion of ...

  24. Elevated uric acid is associated with a low bone mineral ...

    Introduction The role of uric acid (UA) on bone metabolism is controversially discussed. Higher UA levels have been associated with higher T-scores and a reduced incidence of fractures in postmenopausal women. However, in the context of rheumatoid arthritis (RA), the role of UA remains unclear. This pilot study aimed to investigate the association of UA levels with bone mineral density in RA ...

  25. Predictors of functional improvement and pain reduction in rheumatoid

    Rheumatoid arthritis (RA) patients sometimes exhibit different levels of improvement in health assessment questionnaire-disability index (HAQ-DI) and subjective pain visual analogue score (VAS) even after achieving low disease activities (LDA). This study aimed to identify factors associated with improvement in HAQ-DI and pain VAS among those who achieved LDA.

  26. Inflammatory activity of rheumatoid arthritis

    The inflammatory activity in the body caused by rheumatoid arthritis is linked to specific cognitive impairments, finds a small comparative study, published in the open access journal RMD ...

  27. Host-microbiota interactions in rheumatoid arthritis

    Several studies on experimental murine arthritis have clearly demonstrated the importance of the intestinal microbiota in the pathogenesis of arthritis (Table 1).When mice are reared in germ-free ...

  28. Rheumatoid arthritis and adverse pregnancy outcomes: a ...

    Background: There is growing evidence of bidirectional associations between rheumatoid arthritis and adverse pregnancy outcomes (APOs) in observational studies, but little is known about the causal direction of these associations. Therefore, we explored the potential causal relationships between rheumatoid arthritis and APOs using a bidirectional two-sample Mendelian randomization (MR) in ...

  29. Experimental AI method boosts doctors' ability to diagnose cancers and

    Rheumatoid arthritis; Schizophrenia; ... Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus ... The 3,117 patients in the study were all over the ...

  30. Rheumatoid arthritis can be prevented, study shows

    Rheumatoid arthritis can be prevented, a breakthrough Lancet study has found. Weekly injections of the drug, abatacept, cut the risk of developing the auto-immune disease by 80 per cent during a ...